In this episode of the Becker Private Equity & Business Podcast, Holly Buckley, chair of the McGuireWoods’ healthcare department, discusses the current state of the healthcare private equity market, why alignment is critical to closing successful deals, and how leadership, culture, and AI adoption are shaping organizations built to last.
The Healthcare Investor
Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses
Blog Authors
Latest from The Healthcare Investor
Healthcare & Life Sciences Private Equity Deal Tracker: Incline Invests in West Physics
Incline Equity Partners has announced an investment in West Physics.
West Physics, founded in 2002 and based in Atlanta, is a provider of medical and health physics testing and consulting services.
Incline, founded in 2011 and based in Pittsburgh, Pennsylvania, .is a private equity firm that invests across the middle market in services,…
Healthcare & Life Sciences Private Equity Deal Tracker: TA Associates Invests in AIRS Medical
TA Associates has made a growth investment in AIRS Medical, according to a news release.
AIRS Medical, founded in 2018 and headquartered in Seoul, South Korea, with a U.S. office in Schaumburg, Illinois, is a global provider of AI solutions for medical imaging.
TA, founded in 1968 and based in Boston, considers…
Healthcare Compliance as a Deal Asset, With Wiks Moffat
Compliance is no longer a fire drill to be ignored. Wiks Moffat, founder and CEO of Calyx Compliance with 30 years of healthcare compliance experience, says the enforcement environment has accelerated, with AI now helping regulators spot outliers.
In conversation with McGuireWoods partner and host Geoff Cockrell, Wiks explains how most companies still aren’t…
Healthcare & Life Sciences Private Equity Deal Tracker: Cleargate Invests in Fellow Health
Cleargate Capital Partners has invested in Fellow Health Partners, according to a news release.
Fellow, founded in 2017 and based in Great River, New York, is a provider of revenue cycle management services to physician groups, ambulatory surgery centers and healthcare organizations.
Cleargate, founded in 2025 and based in Chicago, is a…
How Infusion Services Became a Private Equity Hotspot with Amber Walsh of McGuireWoods
In this episode of the Becker Private Equity & Business Podcast, Amber Walsh, Partner at McGuireWoods LLP, explores why infusion services have become a magnet for private equity investment, using the SinglePoint acquisition of Helix Infusion Services to illustrate the broader trends shaping the space.
Healthcare & Life Sciences Private Equity Deal Tracker: Arlington Capital Sells Riverpoint Medical to Novanta
Arlington Capital Partners has announced it has agreed to sell Riverpoint Medical to Novanta.
Riverpoint, founded in 2008 and based in Portland, Oregon, designs, develops and markets medical devices for the healthcare and veterinary markets. The company specializes in the production of surgical solutions — including fiber-based, polymer and bioabsorbable devices and structures —…
Physician Practice Management and Healthcare Private Equity Trends in 2026 with Amber Walsh of McGuireWoods
In this episode of the Becker Private Equity & Business Podcast, Amber Walsh, Partner at McGuireWoods LLP, traces the momentum behind healthcare private equity — the physician specialties drawing the most capital, the staying power of ambulatory surgery center (ASC) strategies, and the market dynamics investors can’t ignore.
The Evolving Landscape of Physician Practice Acquisitions with Holly Buckley
In this episode of the Becker Private Equity & Business Podcast, Holly Buckley, chair of the McGuireWoods’ healthcare department, explores what’s driving private equity interest in physician practice management, which specialties are attracting the most capital, and the operational factors shaping today’s deals.
Healthcare & Life Sciences Private Equity Deal Tracker: WestView Invests in Helio Health
WestView Capital Partners has completed a strategic minority investment in Helio Health Group, according to a news release.
HELIO, founded in 2015 and based in Morristown, New Jersey, is a life sciences consulting and technology firm providing compliance, government pricing and commercial services to pharmaceutical and biotechnology companies, including AI-enabled software solutions.